James Hardie Industries : Q3 FY23 Management Presentation

Q3 FY23 MANAGEMENT PRESENTATION

14 February 2023

James Hardie Q3 FY23 Results

CAUTIONARY NOTE ON FORWARD‐LOOKING STATEMENTS

CAUTIONARY NOTE ON FORWARD‐LOOKING STATEMENTS

This Management Presentation contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. James Hardie Industries plc (the "Company") may from time to time make forward‐looking statements in its periodic reports filed with or furnished to the Securities and Exchange Commission on Forms 20‐F and 6‐K, in its annual reports to shareholders, in media releases and other written materials and in oral statements made by the Company's officers, directors or employees to analysts, institutional investors, representatives of the media and others. Words such as "believe," "anticipate," "plan," "expect," "intend," "target," "estimate," "project," "predict," "forecast," "guideline," "aim," "will," "should," "likely," "continue," "may," "objective," "outlook" and similar expressions are intended to identify forward‐looking statements but are not the exclusive means of identifying such statements. These forward‐looking statements are based upon management's current expectations, estimates, assumptions and beliefs concerning future events and conditions. Readers are cautioned not to place undue reliance on any forward‐ looking statements.

Forward‐looking statements are necessarily subject to risks, uncertainties and other factors, many of which are unforeseeable and beyond the Company's control. Many factors could cause actual results, performance or achievements to be materially different from those expressed or implied in this Management Presentation, including, among others, the risks and uncertainties set forth in Section 3 "Risk Factors" in James Hardie's Annual Report on Form 20‐F for the year ended 31 March 2022; changes in general economic, political, governmental and business conditions globally and in the countries in which the Company does business, including the impact of COVID‐19; changes in interest rates; changes in inflation rates; changes in exchange rates; the level of construction generally; changes in cement demand and prices; changes in raw material and energy prices; changes in business strategy and various other factors. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. James Hardie assumes no obligation to update or correct the information contained in this Management Presentation except as required by law.

USE OF NON‐GAAP FINANCIAL INFORMATION; AUSTRALIAN EQUIVALENT TERMINOLOGY

This Management Presentation includes financial measures that are not considered a measure of financial performance under generally accepted accounting principles in the United States (GAAP). These financial measures are designed to provide investors with an alternative method for assessing our performance from on‐going operations, capital efficiency and profit generation. Management uses these financial measures for the same purposes.

These financial measures are or may be non‐GAAP financial measures as defined in the rules of the U.S. Securities and Exchange Commission and may exclude or include amounts that are included or excluded, as applicable, in the calculation of the most directly comparable financial measures calculated in accordance with GAAP. These non‐GAAP financial measures should not be considered to be more meaningful than the equivalent GAAP measure. Management has included such measures to provide investors with an alternative method for assessing its operating results in a manner that is focused on the performance of its ongoing operations and excludes the impact of certain legacy items, such as asbestos adjustments. Additionally, management uses such non‐GAAP financial measures for the same purposes. However, these non‐GAAP financial measures are not prepared in accordance with GAAP, may not be reported by all of the Company's competitors and may not be directly comparable to similarly titled measures of the Company's competitors due to potential differences in the exact method of calculation. For additional information regarding the non‐GAAP financial measures presented in this Management Presentation, including a reconciliation of each non‐GAAP financial measure to the equivalent GAAP measure, see the slide titled "Non‐GAAP Financial Measures" included in the Appendix to this Management Presentation.

In addition, this Management Presentation includes financial measures and descriptions that are considered to not be in accordance with GAAP, but which are consistent with financial measures reported by Australian companies, such as operating profit, EBIT and EBIT margin. Since the Company prepares its Consolidated Financial Statements in accordance with GAAP, the Company provides investors with definitions and a cross‐reference from the non‐GAAP financial measure used in this Management Presentation to the equivalent GAAP financial measure used in the Company's Consolidated Financial Statements. See the section titled "Non‐GAAP Financial Measures" included in the Appendix to this Management Presentation.

Page 2

James Hardie Q3 FY23 Results

AGENDA

• Q3 FY23 Financial Results
• Strategy and Operations Update

Aaron Erter

CEO

• Questions and Answers

Jason Miele

CFO

Page 3

Q3 FY23 FINANCIAL RESULTS

James Hardie Q3 FY23 Results

GLOBAL RESULTS

	Q3 FY23		9 Months FY23
Sales Volume	1,026.4 mmsf	3,403.3 mmsf
-11%	-2%
Net Sales	US$860.8	M	US$2,859.3 M
-4%	+8%
Adjusted EBIT1	US$165.4	M	US$592.3 M
-19%	FLAT
Adjusted Net Income2	US$129.2	M	US$459.3 M
-16%	+4%
Operating Cash Flow			US$432.1 M
		-22%
Adjusted EBITDA Margin1	24.3	%	25.1 %
-3.0 pts	-1.7 pts

All changes presented are versus prior corresponding period

1 Excludes asbestos related expenses and adjustments

2 Excludes asbestos related expenses and adjustments, and tax adjustments

• All 3 regions are simultaneously executing on the Global Strategy
• 4% decrease in Q3 FY23 Net Sales
• 19% decrease in Q3 FY23 Adjusted EBIT
• 16% decrease in Q3 FY23 Adjusted Net Income
• 8% increase in YTD Net Sales and a 4% increase in YTD Adjusted Net Income
• Restructuring
• • Global head count reduction of approximately 6%
  • Restructuring charges of US$6.0 million in the third quarter

Page 5